100 related articles for article (PubMed ID: 7654034)
1. Detection of p53 and MDM2 protein expression in head and neck carcinogenesis.
Girod SC; Cesarz D; Fischer U; Krueger GR
Anticancer Res; 1995; 15(4):1453-7. PubMed ID: 7654034
[TBL] [Abstract][Full Text] [Related]
2. p53 and PCNA expression in carcinogenesis of the oropharyngeal mucosa.
Girod SC; Pape HD; Krueger GR
Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):419-23. PubMed ID: 7719225
[TBL] [Abstract][Full Text] [Related]
3. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
Agarwal S; Mathur M; Srivastava A; Ralhan R
Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the immunoreactivity of three anti-p53 antibodies and estimation of the relations between p53 status and MDM2 protein expression in ovarian carcinomas.
Harlozińska A; Bar J; Montenarh M
Anticancer Res; 2000; 20(2A):1049-56. PubMed ID: 10810396
[TBL] [Abstract][Full Text] [Related]
5. p53 and MDM2 expression in oral squamous cell carcinoma.
Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
[TBL] [Abstract][Full Text] [Related]
6. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
[TBL] [Abstract][Full Text] [Related]
7. Expression of P53, MDM2 and Ki-67 antigens in soft tissue sarcomas.
Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
Pol J Pathol; 1999; 50(1):9-16. PubMed ID: 10412269
[TBL] [Abstract][Full Text] [Related]
8. [The expression of Mdm2 protein and p53 mutation in lung squamous cell carcinomas and their clinicopathological significance].
Zhang J; Liu H; Li S; Gu C
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):163-5. PubMed ID: 11812371
[TBL] [Abstract][Full Text] [Related]
9. Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma.
Soslow RA; Shen PU; Chung MH; Isacson C
Int J Gynecol Pathol; 1998 Apr; 17(2):129-34. PubMed ID: 9553809
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the expression of p53, MDM2, and SUMO-1 in oral lichen planus.
Oliveira Alves M; Balducci I; Rodarte Carvalho Y; Cabral L; Nunes F; Almeida J
Oral Dis; 2013 Nov; 19(8):775-80. PubMed ID: 23350884
[TBL] [Abstract][Full Text] [Related]
11. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis.
Blok P; Craanen ME; Dekker W; Offerhaus GJ; Tytgat GN
J Pathol; 1998 Sep; 186(1):36-40. PubMed ID: 9875138
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical status of p53, mdm2 and Ki-67 in malignant fibrous histiocytoma.
Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
Pol J Pathol; 1998; 49(1):15-21. PubMed ID: 9640970
[TBL] [Abstract][Full Text] [Related]
13. p53 and MDM2 protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract.
Ambrosch P; Ruschenburg I
Anticancer Res; 2000; 20(5A):3151-5. PubMed ID: 11062736
[TBL] [Abstract][Full Text] [Related]
14. Nuclear accumulation of MDM2 protein in well-differentiated papillary thyroid carcinomas.
Jennings T; Bratslavsky G; Gerasimov G; Troshina K; Bronstein M; Dedov I; Alexandrova G; Figge J
Exp Mol Pathol; 1995 Jun; 62(3):199-206. PubMed ID: 8612724
[TBL] [Abstract][Full Text] [Related]
15. [Interaction between p53 and MDM2 in human lung cancer cells].
Rybárová S; Hodorová I; Vecanová J; Muri J; Mihalik J
Klin Onkol; 2014; 27(1):33-7. PubMed ID: 24635435
[TBL] [Abstract][Full Text] [Related]
16. p53 and mdm-2 expression in malignant melanoma: an immunocytochemical study of expression of p53, mdm-2, and markers of cell proliferation in primary versus metastatic tumors.
Gelsleichter L; Gown AM; Zarbo RJ; Wang E; Coltrera MD
Mod Pathol; 1995 Jun; 8(5):530-5. PubMed ID: 7675773
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of Mdm2 and p53 in penile verrucous carcinoma.
Ouban A; Dellis J; Salup R; Morgan M
Ann Clin Lab Sci; 2003; 33(1):101-6. PubMed ID: 12661905
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of p53 and MDM2 proteins in cervical neoplasia.
Lukás Z; Vojtĕsek B; Anton M; Picksley SM; Kubálek V
Folia Biol (Praha); 1995; 41(3-4):197-9. PubMed ID: 7589715
[TBL] [Abstract][Full Text] [Related]
19. [TP53 gene aberrations in chondromatous neoplasms: correlation with immunohistochemical p53 accumulation and MDM2 expression].
Blasenbreu S; Baretton GB; Bender C; Haas CJ; Diebold J; Löhrs U
Verh Dtsch Ges Pathol; 1998; 82():284-9. PubMed ID: 10095448
[TBL] [Abstract][Full Text] [Related]
20. Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration: prognostic significance.
Molina P; Pellín A; Navarro S; Boix J; Carda C; Llombart-Bosch A
Virchows Arch; 1999 Dec; 435(6):596-605. PubMed ID: 10628802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]